Evogene Refocuses Corn Disease Collaboration With Bayer
July 16 2019 - 7:57AM
Dow Jones News
By Michael Dabaie
Evogene Ltd. (EVGN) said its corn disease resistance research
collaboration with the Crop Science Division of Bayer AG (BAYN.XE)
is being refocused on identifying genome editing targets for
evaluation against a broad range of corn diseases.
The amended agreement follows positive results in corn stalk rot
fungal disease control, biotechnology company Evogene said.
Evogene shares were up 6.5% premarket, to $1.64.
Evogene will use its Computational Predictive Biology platform
to identify the required edits to improve disease resistance in
corn. Any promising targets would be pursued by Bayer's in-house
team for validation, Evogene said.
The collaboration aims to develop improved corn seeds with
resistance to fungal diseases.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
July 16, 2019 07:42 ET (11:42 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Apr 2023 to Apr 2024
